Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122111682 | 12211168 | 2 | F | 20160316 | 20160720 | 20160325 | 20160729 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-021202 | BRISTOL MYERS SQUIBB | 58.12 | YR | F | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122111682 | 12211168 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, UNK | Y | U | 5F82708B | 21986 | 100 | MG | |||||
| 122111682 | 12211168 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 80 MG, QOD | Y | U | 21986 | 80 | MG | QD | |||||
| 122111682 | 12211168 | 3 | C | IBUPROFEN. | IBUPROFEN | 1 | Oral | 800 MG, PRN | U | 0 | 800 | MG | |||||||
| 122111682 | 12211168 | 4 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 122111682 | 12211168 | 5 | C | MELATONIN | MELATONIN | 1 | Oral | 3 MG, PRN | U | 0 | 3 | MG | |||||||
| 122111682 | 12211168 | 6 | C | TOPIRAMATE. | TOPIRAMATE | 1 | Oral | 100 MG, QHS | U | 0 | 100 | MG | QD | ||||||
| 122111682 | 12211168 | 7 | C | COMPAZINE | PROCHLORPERAZINE MALEATE | 1 | Oral | 10 MG, PRN | U | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122111682 | 12211168 | 1 | Chronic myeloid leukaemia |
| 122111682 | 12211168 | 3 | Product used for unknown indication |
| 122111682 | 12211168 | 4 | Product used for unknown indication |
| 122111682 | 12211168 | 5 | Product used for unknown indication |
| 122111682 | 12211168 | 6 | Product used for unknown indication |
| 122111682 | 12211168 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122111682 | 12211168 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122111682 | 12211168 | Bone marrow failure | |
| 122111682 | 12211168 | Dyspnoea | |
| 122111682 | 12211168 | Fatigue | |
| 122111682 | 12211168 | Full blood count decreased | |
| 122111682 | 12211168 | Nausea | |
| 122111682 | 12211168 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122111682 | 12211168 | 1 | 20160204 | 0 | ||
| 122111682 | 12211168 | 2 | 20160316 | 0 |